The project aims to develop the CRISPR/Cas9 genetic edition technique in human embryos to study their development
Month: April 2020
The projects include new therapies, the use of commercialized drugs for other indications and genetic studies, and some could reach the population before the end of the year.
The IDIBELL and the Bellvitge University Hospital projects are led by the groups of Dr. Jordi Carratalá, Dr. Rafael Mañez, and Dr. Xavier Solanich.
The call has been promoted by the General Directorate of Research and Innovation in Health (DGRI) with the collaboration of AQuAS and Biocat.